Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
Resources, news and special offers to support you and your professional development during this difficult time.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
Download your copy of the new events calendar and see all the online workshops, conferences, RAC exams and European online workshops RAPS has planned for 2021 at a glance.
Registration is now open for RAPS Euro Convergence 2021! Attend to join peers from EU and around the world to gain insights and exchange ideas on the regions most pressing issues.
An invaluable resource for any professional engaged in designing, composing, compiling, or commenting on regulatory documentation
From self-assessments to help you identify your strengths and areas to focus on to reference books and online courses that will help you fill in the gaps in your regulatory knowledge, RAPS has the resources to help you prepare for the RAC exam.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
Posted 20 January 2016 | By Zachary Brennan
Australia’s Therapeutic Goods Administration (TGA) is calling attention to medical device battery issues, particularly for implantable devices, and saying manufacturers and health facilities should adopt procedures to reduce risk.
A battery-related problem was listed as a potential contributing factor in more than 50 adverse event reports over the past 10 years involving deaths or serious injuries, the Australian regulator said, noting a range of safety alerts over the past three years for cardiac defibrillators, implantable pulse generators, ventricular assist devices and pacemakers.
Of the 345 battery-related reports from January 2013 to October 2015, TGA said in a safety bulletin that active implantable medical devices (AIMDs) are “dominating the battery failure reports.”
The batteries on AIMDs are generally non-rechargeable and replacement would require surgery, TGA notes, though investigations “usually reveal battery depletion is due to excess current drain (low circuit impedances, high output settings and the like) and not generally battery failure.”
In addition to battery problems with AIMDs, there have been reports on the batteries of other devices such as infusion pumps, insulin pumps, patient monitors and vision systems.
The most common kinds of battery failures are for rechargeable batteries that fail to charge, fail to hold a charge or are not inserted correctly.
The US Food and Drug Administration previously conducted a survey on device battery issues and found many of these problems, especially those related to large-volume infusion pumps, may be attributed to staff practices and poor maintenance practices, and not the actual devices.
TGA said users should follow the battery replacement and maintenance recommendations set out by the original equipment manufacturer so that both the device and battery performance will be as expected and certified by the manufacturer.
Health facilities and companies should also establish suitable protocols and procedures to optimize battery management and reduce risks, TGA said, noting other considerations:
TGA
Tags: TGA, medical device batteries, implantable device batteries, pacemakers
Regulatory Focus newsletters
All the biggest regulatory news and happenings.